Oxford Nanopore Technologies develops and commercializes a novel generation of DNA/RNA sequencing technology that provides rich data, is fast, accessible and easy to use. The company's nanopore sequencing platform offers real-time analysis in fully scalable formats from pocket-sized devices like MinION to high-throughput benchtop systems like PromethION. The technology uniquely sequences native DNA and RNA, enabling short to ultra-long read lengths without the need for amplification or labeling.
Founded in 2005 as a spin-out from the University of Oxford, the company employs more than 1000 people across multiple disciplines including nanopore science, molecular biology, informatics, engineering, and manufacturing. Oxford Nanopore's goal is to enable the analysis of anything, by anyone, anywhere. The technology is used across scientific research, healthcare, and industrial applications, powering breakthroughs in microbial genomics, human genomics, cancer research, infectious disease surveillance, and environmental studies in over 120 countries worldwide.